Homeostasis of the ER redox state subsequent to proteasome inhibition.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 04 2021
Historique:
received: 08 09 2020
accepted: 07 04 2021
entrez: 22 4 2021
pubmed: 23 4 2021
medline: 16 11 2021
Statut: epublish

Résumé

Endoplasmic reticulum (ER) maintains within, an oxidative redox state suitable for disulfide bond formation. We monitored the ER redox dynamics subsequent to proteasome inhibition using an ER redox probe ERroGFP S4. Proteasomal inhibition initially led to oxidation of the ER, but gradually the normal redox state was recovered that further led to a reductive state. These events were found to be concomitant with the increase in the both oxidized and reduced glutathione in the microsomal fraction, with a decrease of total intracellular glutathione. The ER reduction was suppressed by pretreatment of a glutathione synthesis inhibitor or by knockdown of ATF4, which induces glutathione-related genes. These results suggested cellular adaptation of ER redox homeostasis: (1) inhibition of proteasome led to accumulation of misfolded proteins and oxidative state in the ER, and (2) the oxidative ER was then reduced by ATF4 activation, followed by influx of glutathione into the ER.

Identifiants

pubmed: 33883613
doi: 10.1038/s41598-021-87944-y
pii: 10.1038/s41598-021-87944-y
pmc: PMC8060268
doi:

Substances chimiques

Fluorescent Dyes 0
Molecular Probes 0
Proteasome Endopeptidase Complex EC 3.4.25.1
Glutathione GAN16C9B8O
Dimethyl Sulfoxide YOW8V9698H

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8655

Références

Mol Cell. 2017 Sep 21;67(6):962-973.e5
pubmed: 28918898
J Biol Chem. 2012 Nov 16;287(47):39513-23
pubmed: 23027870
Traffic. 2020 Jun;21(6):419-429
pubmed: 32246734
J Neurol Sci. 2011 Aug 15;307(1-2):157-61
pubmed: 21641618
Int J Biochem Cell Biol. 2002 Nov;34(11):1461-74
pubmed: 12200039
Cell. 2008 Nov 28;135(5):933-47
pubmed: 19026441
EMBO Rep. 2006 Mar;7(3):271-5
pubmed: 16607396
Annu Rev Cell Dev Biol. 2002;18:575-99
pubmed: 12142265
J Biol Chem. 2000 Feb 18;275(7):4827-33
pubmed: 10671517
Nature. 2002 Jan 3;415(6867):92-6
pubmed: 11780124
Science. 2000 Nov 24;290(5496):1571-4
pubmed: 11090354
Neurobiol Aging. 2012 May;33(5):1007.e9-17
pubmed: 22056200
Science. 2005 Feb 11;307(5711):935-9
pubmed: 15705855
Mol Cell Biol. 2014 Sep 15;34(18):3421-34
pubmed: 25002527
Antioxid Redox Signal. 2010 Sep 15;13(6):721-9
pubmed: 20095866
Nat Rev Mol Cell Biol. 2012 Jan 18;13(2):89-102
pubmed: 22251901
Cell. 2007 Apr 20;129(2):333-44
pubmed: 17448992
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11291-11298
pubmed: 31101715
Science. 1992 Sep 11;257(5076):1496-502
pubmed: 1523409
Nat Rev Drug Discov. 2013 Sep;12(9):703-19
pubmed: 23989796
EMBO J. 2015 Sep 14;34(18):2334-49
pubmed: 26228940
Nature. 2003 Dec 18;426(6968):891-4
pubmed: 14685249
J Cell Biol. 2004 Oct 11;167(1):27-33
pubmed: 15479734
Mol Cell. 2003 Mar;11(3):619-33
pubmed: 12667446
Sci Rep. 2014 Jul 31;4:5896
pubmed: 25077633
Biosci Rep. 2016 Apr 15;36(2):
pubmed: 26934978
Mol Cell. 2011 Feb 18;41(4):432-44
pubmed: 21329881
Nat Rev Mol Cell Biol. 2008 Dec;9(12):944-57
pubmed: 19002207
Sci Rep. 2016 Sep 16;6:32886
pubmed: 27633668
Elife. 2014 Jul 22;3:e03496
pubmed: 25053742
Biochem J. 2011 Mar 1;434(2):181-8
pubmed: 21309747
J Biol Chem. 2010 Mar 5;285(10):7135-42
pubmed: 20056998
J Biochem. 2010 Jan;147(1):19-25
pubmed: 19923195
Hum Mol Genet. 2008 Mar 15;17(6):906-17
pubmed: 18065497
Mol Biol Cell. 1999 Nov;10(11):3787-99
pubmed: 10564271
Nature. 1999 Jan 21;397(6716):271-4
pubmed: 9930704
Science. 2008 Jul 25;321(5888):569-72
pubmed: 18653895
EMBO J. 2010 Oct 6;29(19):3318-29
pubmed: 20802462
Nat Rev Mol Cell Biol. 2007 Jul;8(7):519-29
pubmed: 17565364
EMBO J. 2008 Nov 19;27(22):2988-97
pubmed: 18971943
FEBS Lett. 2013 Mar 18;587(6):793-8
pubmed: 23416294
EMBO J. 2008 Nov 19;27(22):2977-87
pubmed: 18833192
Nat Rev Mol Cell Biol. 2003 Mar;4(3):181-91
pubmed: 12612637

Auteurs

Yuki Oku (Y)

Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.
Graduate School of Advanced Integrated Studies in Human Survivability, Kyoto University, Kyoto, 606-8306, Japan.

Masahiro Kariya (M)

Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.

Takaaki Fujimura (T)

Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.

Jun Hoseki (J)

Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan. hoseki.jun@kuas.ac.jp.
Research Unit for Physiological Chemistry, the Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto, 606-8502, Japan. hoseki.jun@kuas.ac.jp.
Department of Bioscience and Biotechnology, Faculty of Bioenvironmental Science, Kyoto University of Advanced Science, Kyoto, 621-8555, Japan. hoseki.jun@kuas.ac.jp.

Yasuyoshi Sakai (Y)

Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.
Graduate School of Advanced Integrated Studies in Human Survivability, Kyoto University, Kyoto, 606-8306, Japan.
Research Unit for Physiological Chemistry, the Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto, 606-8502, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH